Literature DB >> 31345329

The Gut Microbiome Influences Responses to Programmed Death 1 Therapy in Chinese Lung Cancer Patients - the Benefits of Diversity.

Eric H Bernicker1, Eamonn M M Quigley2.   

Abstract

Entities:  

Year:  2019        PMID： 31345329     DOI： 10.1016/j.jtho.2019.05.016

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  5 in total

Review 1.  Modulation of the intestinal microbiota impacts the efficacy of immunotherapy in cancer patients - A recent literature survey.

Authors:  Stella Ziegler; Stefan Bereswill; Markus M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2022-09-23

2.  Gut Microbiome Was Highly Related to the Regulation of Metabolism in Lung Adenocarcinoma Patients.

Authors:  Sheng Wang; Huachun Chen; Huizhen Yang; Kejin Zhou; Fan Bai; Xiaoyu Wu; Hanwen Xu
Journal:  Front Oncol       Date:  2022-05-03       Impact factor: 5.738

Review 3.  [Research Progress, Benefit Groups, Treatment Cycle and Efficacy Prediction 
of Neoadjuvant Immunotherapy for Non-small Cell Lung Cancer].

Authors:  Jingbin Ji; Chenyu Zhang; Lei Peng; Wenjie Jiao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-02-20

4.  Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion.

Authors:  Rahul Ravilla; Hannah N Coleman; Cheryl-Emiliane Chow; Luisa Chan; Barbara J Fuhrman; William W Greenfield; Michael Scott Robeson; Kathryn Iverson; Horace Spencer; Mayumi Nakagawa
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

Review 5.  Diet, Microbiome, and Cancer Immunotherapy-A Comprehensive Review.

Authors:  Michał Szczyrek; Paulina Bitkowska; Patryk Chunowski; Paulina Czuchryta; Paweł Krawczyk; Janusz Milanowski
Journal:  Nutrients       Date:  2021-06-28       Impact factor: 5.717
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.